Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "NTU"

1062 News Found

Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care
Hospitals | April 13, 2026

Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care

Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems


Haemonetics gains FDA nod to expand VASCADE MVP XL for larger sheaths in heart procedures
Technology | April 12, 2026

Haemonetics gains FDA nod to expand VASCADE MVP XL for larger sheaths in heart procedures

The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths


Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
Digitisation | April 10, 2026

Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses

The device aims to bring precision neuroscience into clinical trials, accelerating drug development


Biocon appoints Mandar Ghatnekar as Chief Technology Officer
People | April 10, 2026

Biocon appoints Mandar Ghatnekar as Chief Technology Officer

Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role


Lupin scores major US breakthrough with FDA nod for key diabetes drug
Drug Approval | April 10, 2026

Lupin scores major US breakthrough with FDA nod for key diabetes drug

The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets


Maharashtra MEMS 108 gets 1,756 new ambulances as Sumeet SSG partners Pinnacle
Healthcare | April 09, 2026

Maharashtra MEMS 108 gets 1,756 new ambulances as Sumeet SSG partners Pinnacle

36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108


Dabur reports steady domestic growth amid global headwinds in Q4 FY26
News | April 08, 2026

Dabur reports steady domestic growth amid global headwinds in Q4 FY26

The India FMCG business showed a sequential recovery and is expected to post high-single digit growth


Stipple Bio raises $100M Series A to advance next-gen cancer therapies
Biotech | April 08, 2026

Stipple Bio raises $100M Series A to advance next-gen cancer therapies

The new capital is expected to fund the company through 2029